Scopus BioPharma’s Subsidiary — Duet Therapeutics — Announces Release of Preclinical Data Being Presented at 17th Annual Meeting of the Oligonucleotide Therapeutics Society
Data from two different studies benchmark Duet’s proprietary bifunctional oligonucleotides against immune checkpoint inhibitors (“Checkpoint…
OpenEnvoy Launches Ask OE to Solve Enterprise Finance AI’s Foundational Problem
Fortinet launches Singapore NDR cloud PoP to strengthen threat detection across ASEAN